Syncona Ltd - London-based investor in healthcare companies - Notes that the loss of investee and clinical-stage biopharmaceutical company Achilles Therapeutics PLC narrows by 2.7% to USD68.2 million...

Related Keywords

London , City Of , United Kingdom , Miraj Ali , Tom Budszus , Syncona Ltd , Alliance News Ltd , Alliance News , Achilles Therapeutics , Achilles Chief Executive Officer Iraj Ali , All Rights , Markets ,